News & events

SUPPORT-Meds aims to bridge the gap between existing evidence-based guidelines and everyday clinical practice by providing practical, evidence-based resources.

MIPS researchers used a validated laboratory infection system to expose bacterial samples from infected patients to simulated antibiotic dosing regimens, as would actually occur in hospitalised patients.

MIPS researchers have found in laboratory experiments that a drug which delivers copper to the brain significantly reduces toxic Alzheimer’s proteins and improves long-term spatial memory.

Monash University is calling on healthcare professionals and the broader community to help shape the future of dementia care, opening public consultation on the first major draft update to the national clinical guidelines.

The Faculty of Pharmacy and Pharmaceutical Sciences thanks Liz Stock for her committed service between 2001–2026, and wishes her all the very best for retirement.

Professor Arthur Christopoulos, FAA, FAHMS, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, has been honoured with a prestigious 2025 Research Excellence Award from NHMRC

MIPS researchers have unlocked the blueprint of how Australia’s health system can make better use of antenatal lifestyle coaching to improve patient outcomes and dismantle entrenched health inequality.

xCystence Bio is developing a pipeline of Targeted Protein Degraders (TPDs) designed to remove the Aurora kinase A (AURKA) protein, which plays a key role in cyst formation and disease progression in ADPKD.

Monash is one of the top universities in the world for Pharmacy and Pharmacology with a second place spot in the 2026 Quacquarelli Symonds (QS) World University Rankings by Subject.